Bone Support
Bone Support, licence 80097032: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Bone Care, Bone Health
- Licence holder
- Ovensa Inc.
- NPN or DIN-HM
- 80097032
- Status
- Active licence
- Licence date
- 9 February 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 21 µg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Calcium: up to 1,500 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 800 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Poly-bêta-(1,4)-2-amino-2-désoxy-d-glucose Source : Carapace de crevette | 100.0 mg | Not calculated |
| Acide L-ascorbique Source : Acide ascorbique | 50.0 mg | Not calculated |
| Cannabis sativa Source : Graine(s) | 100.0 mg | Not calculated |
| Vitamine D Source : Cholécalciférol | 7.0 mcg | 21 µg |
| Calcium Source : Calcium Carbonate from Oyster Shell | 500.0 mg | 1,500,000 µg |
| Magnésium Source : Oxyde de magnésium | 50.0 mg | 150,000 µg |
Non-medicinal ingredients
Hydroxypropylméthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 3.0 Jour(s) |
Uses authorised in Canada
Helps in the development and maintenance of bones, cartilage, teeth and/or gums and in connective tissue formation. Helps to build strong bones and teeth. As part of a healthy diet (when taken with Vitamin D) may help prevent bone loss/osteoporosis. Helps support bone health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
May cause abdominal pain, bloating, constipation, indigestion and/or diarrhea.
Source
Official Health Canada record, licence 80097032
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.